MedTrace Logo

Evaluation of the Safety and Tolerability of Ocular Lubricants

NCT06571656 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2025-08-17

No results posted yet for this study

Summary

The purpose of this study is to evaluate the safety and tolerability of three new artificial tear formulations in subjects with moderate dry eye disease.

Conditions

Interventions

OTHER

FID123359 test formulation

Investigational product

OTHER

FID123360 test formulation

Investigational product

OTHER

FID123361 test formulation

Investigational product

OTHER

FID121843 ocular lubricant

Commercially available, preservative-free eye drops

Sponsors & Collaborators

  • Alcon Research

    lead INDUSTRY

Principal Investigators

  • Clinical Trial Lead, Dry Eye · Alcon Research, LLC

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-02
Primary Completion
2025-07-11
Completion
2025-07-11

Countries

  • Australia

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06571656 on ClinicalTrials.gov